| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| PROCEPT BioRobotics Corp | Director | Common Stock | 12,561 | $667,114 | $53.11 | 10 Jun 2025 | Direct |
| PROCEPT BioRobotics Corp | Director | Stock Option (Right to Buy) | 2,771 | $11,519 | $4.56 | 10 Jun 2025 | Direct |
| VYNE Therapeutics Inc. | Director | Stock Option (right to buy) | 20,000 | 12 Dec 2025 | Direct | ||
| Intersect ENT, Inc. | Director | Stock Options (Right to buy) | 0 | $28.25 | 13 May 2022 | Direct | |
| Satsuma Pharmaceuticals, Inc. | Director | Stock Option (right to buy) | 0 | 08 Jun 2023 | Direct |